Christman joined the company in 2010 and had served as section head for Biostatistics previously. Christman’s experience in interactions with U.S. Food and Drug Administration (FDA) committees, statistical methods in clinical trials particularly the area of adaptive trial design, and the management of statisticians led to her promotion to the director level at STATKING.
“The promotion of these employees strengthens our management network within the company and provides more autonomy for decision making on project work at this management level,” commented Dennis W. King, founder, president and CEO of STATKING Clinical Services. “We continue to move to define more delineated roles for mid and upper management within our company.”
Landenwitsch has been with STATKING for the past seven years and had previously served as section head for Statistical Programming at STATKING. Her expertise in SAS programming, CDISC standards and the management of programming staff led to her promotion to the director level at STATKING.
Rod Lashley, executive vice president and co-owner of STATKING, added: “Lori and Sarah have demonstrated outstanding leadership ability with our staff and our clients. This promotion enables STATKING to continue to provide the highest quality of service to our clients.”
STATKING Clinical Services provides clinical trial services (clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, medical writing, medical monitoring, safety reporting, and project management) for clinical trials for the regulatory approval of drug and medical device products. The company is headquartered in Fairfield, Ohio. The company has provided support on 12 new drug applications, 13 premarket approvalss, 2 biologics license applications, 3 new animal drug applicationss and numerous FDA 510Ks over the past 30 years of service to the pharmaceutical, medical device and animal health industries.